California State Teachers Retirement System (CalSTRS)’s Insight Molecular Diagnostics IMDX Stock Holding History
Bought
Maintained
Sold
Other funds holding IMDX
BC
PVI
AIC
DC
SSA
PM
California State Teachers Retirement System (CalSTRS)'s IMDX Position: Q2 2022 in Review
California State Teachers Retirement System (CalSTRS) sold out of Insight Molecular Diagnostics (IMDX) in Q2 2022, closing a stake of 1,297 shares — an estimated $39K sold.
California State Teachers Retirement System (CalSTRS) first reported a position in IMDX in Q1 2016 and held it in 17 quarters. The position peaked at $562K in Q2 2021. 75 funds tracked by Wall St. Rank hold IMDX as of Q2 2022.
- California State Teachers Retirement System (CalSTRS) reported no remaining Insight Molecular Diagnostics position as of Q2 2022 after selling out during the quarter.
- California State Teachers Retirement System (CalSTRS) sold 1,297 Insight Molecular Diagnostics shares in Q2 2022, an estimated $39K.
- California State Teachers Retirement System (CalSTRS) first reported a position in Insight Molecular Diagnostics in Q1 2016 and held it in 17 quarters.
- California State Teachers Retirement System (CalSTRS)'s Insight Molecular Diagnostics position peaked at $562K in Q2 2021.
- 75 funds tracked by Wall St. Rank held Insight Molecular Diagnostics as of Q2 2022.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2022, filed 15 Aug 2022.